UCB BIOSCIENCES, Inc.

1 marketed · 1 in Phase 3

Quick facts

Marketed products

doxecitine and doxribtimine

Phase 3 pipeline

Lasosamide Oral Solution · Neurology
Lasosamide enhances slow inactivation of voltage-gated sodium channels, thereby stabilizing neuronal membranes and reducing seizure activity.

Phase 1 pipeline

fenfluramine HCl